These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1480725)

  • 1. Psychosocial strategies for maximizing the effects of psychotropic medications for schizophrenia and mood disorder.
    Goldstein MJ
    Psychopharmacol Bull; 1992; 28(3):237-40. PubMed ID: 1480725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia.
    Sajatovic M; Friedman SH; Sabharwal J; Bingham CR
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):3-8. PubMed ID: 15018690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia and bipolar affective disorders: likenesses and differences.
    Klein DF
    Hillside J Clin Psychiatry; 1989; 11(1):3-15. PubMed ID: 2613186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.
    McElroy SL; Dessain EC; Pope HG; Cole JO; Keck PE; Frankenberg FR; Aizley HG; O'Brien S
    J Clin Psychiatry; 1991 Oct; 52(10):411-4. PubMed ID: 1938976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between psychosocial adjustment and executive function in patients with bipolar disorder and schizophrenia in remission: the mediating and moderating effects of insight.
    Yen CF; Cheng CP; Huang CF; Ko CH; Yen JY; Chang YP; Chen CS
    Bipolar Disord; 2009 Mar; 11(2):190-7. PubMed ID: 19267701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder.
    Pomykacz B; Mao M; Weiss RD; Teter CJ
    Harv Rev Psychiatry; 2007; 15(5):259-63. PubMed ID: 17924260
    [No Abstract]   [Full Text] [Related]  

  • 7. Haloperidol decanoate.
    Nasser J; Thomas B
    Aust N Z J Psychiatry; 1989 Sep; 23(3):311-2. PubMed ID: 2803140
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
    Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
    Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of obesity on health-related quality of life in schizophrenia and bipolar disorder.
    Kolotkin RL; Corey-Lisle PK; Crosby RD; Swanson JM; Tuomari AV; L'italien GJ; Mitchell JE
    Obesity (Silver Spring); 2008 Apr; 16(4):749-54. PubMed ID: 18239573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressed emotion, maintenance pharmacotherapy, and schizophrenic relapse among Mexican-Americans.
    Jenkins JH; Karno M; de la Selva A; Santana F; Telles C; Lopez S; Mintz J
    Psychopharmacol Bull; 1986; 22(3):621-7. PubMed ID: 3797568
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
    Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic and clinical features of schizoaffective (schizobipolar) disorder--a 5-year retrospective study. Support for a bipolar spectrum disorder.
    Nardi AE; Nascimento I; Freire RC; de-Melo-Neto VL; Valença AM; Dib M; Soares-Filho GL; Veras AB; Mezzasalma MA; Lopes FL; de Menezes GB; Grivet LO; Versiani M
    J Affect Disord; 2005 Dec; 89(1-3):201-6. PubMed ID: 16202454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia.
    Glahn DC; Barrett J; Bearden CE; Mintz J; Green MF; Serap Monkul E; Najt P; Soares JC; Velligan DI
    Psychol Med; 2006 Aug; 36(8):1085-95. PubMed ID: 16734948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in advancing mental and physical health of patients with serious mental illness.
    Dursun S; Dinan TG; Bushe C; Thakore J
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):3-5. PubMed ID: 16280332
    [No Abstract]   [Full Text] [Related]  

  • 19. Coping style of schizophrenic patients in recovery from acute psychotic state.
    Yagi G; Kinoshita F; Nakamura A; Koshiishi M; Kanba S
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):75-8. PubMed ID: 1679275
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of Hunperdal Richter in psychiatry].
    Magyar GI; Fadgyas I
    Neuropsychopharmacol Hung; 2009 Jun; 11(2):111-5. PubMed ID: 19827319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.